Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1658678 · BSEM

BioStem Technologies, Inc.

Filing with the SEC SEC-reporting company Pompano Beach, FL Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Net loss in 2025Net loss of $6.6M for the year (2024: $31M).
  • Revenue downRevenue fell from $69.7M in 2024 to $47.5M in 2025 (32% lower).
  • Private capital raiseOn Oct 9, 2026 the company filed Form D: $3M offered · $3M sold · Biotechnology. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$47.5M$69.7M
Net income (loss)−$6.6M$31M
Total assets$50M$58.3M
Total liabilities$10.9M$18.3M
Stockholders’ equity$39.1M$40M
Cash and equivalents$29.5M$22.8M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
BioStem Technologies, Inc.
Formerly: Biostem Technologies
CIK
0001658678
Tickers
BSEM
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company
Legal form
Corporation
Status
Filing with the SEC
State of incorporation
Florida
Business address
Pompano Beach, Florida
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
None in our data
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Latest exempt offering
$3M offered · $3M sold
Revenue range stated: Decline to Disclose
Bankruptcy reported
Not in our data
Last edition event
Nov 12, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Private raise (Form D): $3M offered · $3M sold · Biotechnology
    Form D · items 06B · filed Oct 9, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Oct 2, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Sep 21, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Sep 18, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 12, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 12, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jul 29, 2026 · filing
  • Form 10 registration: Registration of a class of securities (Form 10)
    Form 10-12G · filed Jul 10, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jun 3, 2026 · filing
  • Form 10 registration: Registration of a class of securities (Form 10)
    Form 10-12B · filed Sep 27, 2024 · filing
  • Private raise (Form D)
    Form D · items 06c · filed Apr 4, 2023 · filing